Risk of dementia after SGLT-2 inhibitors versus DPP-4 inhibitors in adults with type 2 diabetes Post date 28 August 2024 ← Are alternative payment models the answer to the failures of pay-for-performance? → SGLT-2 inhibitors and dementia